Early Reversal of Defunctioning Stoma Trial
- Conditions
- Rectal Cancer
- Registration Number
- NCT00640913
- Lead Sponsor
- Rectal Cancer Trial on Defunctioning Stoma Study Group
- Brief Summary
In this trial will be investigated if a defunctioning loop stoma used in low anterior resection of the rectum for cancer can be reversed after 14 days instead of 3-12 months which is present clinical practise.
- Detailed Description
Patients undergoing low anterior resection of the the rectum for adenocarcinom (total mesorectal excision; TME) with a defunctioning loop stoma are assessed preoperatively and for 6 days postoperatively according to a trial protocol including daily clinical, physiological, and serological variables, and a rectal contrast study on day 6. If inclusion criteria are fulfilled, a decision is taken on day 7 to schedule reversal of the defunctioning loop stoma on postoperative day 14. This trial is considered a hypothesis generating pilot study of feasibility type and is no power calculation. The present trial will include 20 consecutive patients who accept participation.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Written consent and fulfilled inclusion criteria preoperatively and during postoperative day 1-6.
- Written consent and/or inclusion criteria not fulfilled preoperatively and during postoperative day 1-6.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reversal of defunctioning loop stoma on postoperative day 14 following low anterior resection of the rectum for cancer with or without preoperative adjuvant treatment Preoperatively, postoperative day 7, postoperative day 30 and at 6 months postoperatively
- Secondary Outcome Measures
Name Time Method Postoperative 30 day morbidity. Postoperative ano-rectal function at 1 and 6 months. Postoperatively at 1 and 6 months.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Surgery, Örebro University Hospital
🇸🇪Örebro, Sweden
Department of Surgery, Örebro University Hospital🇸🇪Örebro, SwedenRickard Lindgren, MDContact0046 19 602 10 00rickard.lindgren@orebroll.se